Wartovir Wart Remover

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by a rough, cauliflower-like appearance on the surface. Additionally, it is indicated for the removal of plantar warts, which are located exclusively on the bottom of the foot and are identified by tenderness and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. If desired, the wart may be soaked in warm water for approximately 5 minutes to facilitate the application process. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be applied at a time to ensure that each wart is sufficiently covered. It is important to allow the application to dry completely before proceeding. This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

The product is contraindicated in the following situations:

Use is not recommended on irritated skin, infected or reddened areas, in patients with diabetes, or in individuals with poor blood circulation due to the potential for exacerbating these conditions. Additionally, the product should not be applied to moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes, as these areas may pose increased risks of adverse effects.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame.

This product should not be applied to irritated skin, infected or reddened areas, or on individuals with diabetes or poor blood circulation. Additionally, it is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

When using this product, if discomfort persists, it is advised to consult a healthcare professional. In the event that the product comes into contact with the eyes, it is essential to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors associated with this product.

This product must be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

For individuals who are pregnant or breastfeeding, it is recommended to consult a healthcare professional prior to use.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. The product should not be applied to irritated skin, infected areas, or regions affected by diabetes or poor blood circulation. Additionally, it is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

During the use of this product, if discomfort persists, patients are advised to consult their doctor. In the event that the product comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes. Patients should also avoid inhaling vapors associated with the product.

This product should be kept out of reach of children. If ingested, it is imperative to seek medical assistance or contact a Poison Control Center immediately. Furthermore, pregnant or breastfeeding individuals should consult a healthcare professional prior to use to ensure safety.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Wartovir Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as there is no available data to guide treatment decisions in this population. Regular monitoring of renal function may be prudent in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control experts is recommended to guide the management process effectively.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been specified. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to understand the potential risks associated with ingestion and the need for prompt action.

Patients should be informed that if they experience persistent discomfort after using the product, they should consult their doctor for further evaluation and management. This ensures that any underlying issues can be addressed appropriately.

In the event that the product comes into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes. They should be made aware of the importance of this action to minimize potential irritation or damage.

Additionally, healthcare providers should emphasize the importance of avoiding inhalation of vapors from the product. Patients should be counseled on the potential respiratory risks associated with inhaling these vapors and encouraged to use the product in a well-ventilated area.

Storage and Handling

The product is supplied in a container designed to safeguard its integrity. It is essential to protect the product from excessive heat and direct sunlight to maintain its efficacy and safety. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The product is administered topically, with patients instructed to apply one drop at a time using the applicator to adequately cover each wart. This application should be allowed to dry, and the procedure may be repeated once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks.

Clinicians should counsel patients on several important safety measures. If discomfort persists, patients are advised to consult their doctor. In the event of contact with the eyes, the affected area should be flushed with water for 15 minutes. Patients should avoid inhaling vapors and seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Additionally, pregnant or breastfeeding patients should consult a healthcare professional prior to use.

Drug Information (PDF)

This file contains official product information for Wartovir Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)